This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
本资源涵盖的关键主题
For DTx solutions to be integrated into mainstream healthcare, they must secure health authority (HA) approval. In certain scenarios, if the solution offers considerable societal benefits, HAs might even permit DTx to be prescribed by healthcare professionals and, depending on the country, offer reimbursement.
This whitepaper will help you navigate the intricate maze of the current DTx regulatory environment, highlighting several important countries and regulations.
Navigate complex regulatory landscapes with expert guidance across pharmaceuticals, medical devices, and IVD.
继续阅读
白皮书FDA or NMPA approval doesn't mean EU readiness. Learn why home market success often leads to delays under EU MDR, and how to avoid them.
阅读更多
白皮书This whitepaper informs you about digital health, key technology pillars, and new opportunities to anticipate future trends in your healthcare sector.
阅读更多
白皮书Are you up to date with the latest medical device QMS requirements? Download our free ISO 13485:2016 checklist to ensure compliance.
阅读更多